Hyperdense Capsule Sign at Noncontrast CT as an Indication for Middle Meningeal Artery Embolization for Nonacute Subdural Hematomas: A MAGIC-MT Trial Post Hoc Analysis.
A simple CT imaging feature identifies subdural hematoma patients most likely to benefit from less invasive artery-blocking treatment instead of surgery.
Post hoc analysis of the MAGIC-MT RCT identifies the hyperdense capsule sign on routine noncontrast CT as a simple imaging feature that selects patients with nonacute subdural hematomas most likely to benefit from middle meningeal artery (MMA) embolization. Published in Radiology, this study provides practical guidance for procedure selection given growing interest in MMA embolization as a less invasive alternative to surgical drainage.
What the study was
- Study design
- rct_post_hoc
- Population
- Nonacute subdural hematoma patients from MAGIC-MT RCT
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Radiology
Why it surfaced
Radiology publication from a well-designed RCT cohort addressing patient selection for MMA embolization—a rapidly growing minimally invasive neurovascular procedure; identifies a simple CT sign to guide selection, directly improving clinical decision-making for this increasingly common intervention.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.